YAP1 and heart failure: We have shown previously (3) that YAP is activated in response to acute PO, and that cardiac-specific heterozygous downregulation of YAP (YAPch-KO) normalizes nuclear YAP levels, inhibits hypertrophy despite the presence of cardiac dilation, and promotes heart failure during acute PO.